Posted on 7 October 2015
Three decades ago two emerging neuroscientists, Barbara Sahakian and Trevor Robbins from University of Cambridge received a grant to fund their development of the Cambridge Neuropsychological Automated Test Battery or CANTAB™.
Posted on 1 October 2015
From the 8th – 11th October leading scientists and decision-makers in pharma, biotech, clinical sites, and service companies will come together in Boca Raton in Florida for the 6th CNS Summit to shape the future of drug development.
Posted on 30 September 2015
Cambridge Cognition will be attending the 17th annual International Society of Addiction Medicine Congress in Dundee from the 5th – 8th October 2015.
Posted on 25 September 2015
This webinar will discuss the assessment of cognitive function throughout the development of drugs for both CNS and non-CNS indications. It will include a discussion of methodological considerations for the design of clinical trials and approaches to the analysis and interpretation of cognitive outcome measures for the evaluation of both drug efficacy and safety